Teleflex Incorporated (NYSE: TFX) has reported its financial results for the year ended December 31, 2025, and has also provided guidance for the full year 2026. The company announced a GAAP revenue from continuing operations of $1,992.7 million, reflecting a significant increase of 17.2% compared to the prior year period. Adjusted revenue from continuing operations also saw a substantial rise, reaching $1,983.7 million, up 16.3% compared to the prior year period and 15.4% on an adjusted constant currency basis.
In terms of EPS, GAAP diluted EPS from continuing operations amounted to $1.31, compared to $1.21 in the prior year period. Adjusted diluted EPS from continuing operations stood at $6.98, demonstrating an increase from $6.42 in the prior year period.
Looking ahead to 2026, the company has provided guidance for various metrics. The GAAP revenue growth guidance range for the full year 2026 is 14.40% to 15.40%, while the pro forma adjusted constant currency revenue growth guidance range is 4.50% to 5.50%. The company expects GAAP EPS from continuing operations to be in the range of $2.90 to $3.20, and adjusted diluted EPS from continuing operations to range from $6.25 to $6.55.
To support its strategic divestitures, Teleflex has announced a restructuring plan to mitigate $48 million to $52 million of annual stranded costs resulting from the divestitures, with the expectation of achieving annual pre-tax savings once the plan is fully implemented.
In the second half of 2025, the company achieved a GAAP revenue growth of 30.8% compared to the prior period. The pro forma adjusted constant currency revenue growth for this period was 4.7%.
Looking at the breakdown of pro forma adjusted revenue by global product category, in the fiscal year 2025, Vascular intervention revenue was $917.7 million, while Interventional revenue was $647.8 million, and Surgical revenue was $418.2 million.
Teleflex's total cash, cash equivalents, and restricted cash equivalents at December 31, 2025, were $402.7 million, compared to $285.3 million at December 31, 2024. Net accounts receivable at December 31, 2025, were $345.6 million, up from $226.7 million at December 31, 2024. Additionally, inventories at December 31, 2025, amounted to $404.4 million, compared to $306.8 million at December 31, 2024.
The company anticipates a full year 2026 GAAP revenue growth from continuing operations of 14.40% to 15.40%, including an estimated approximately 0.70% positive impact of foreign exchange rate fluctuations. On a pro forma adjusted constant currency basis, the company expects full year 2026 revenue growth from continuing operations of 4.50% to 5.50%.
Teleflex's webcast of its year-end 2025 investor conference call can be accessed live from a link on the company's website at teleflex.com. The call will begin at 8:00 am ET on February 26, 2026. An audio replay of the investor call will also be available beginning at 11:00 am ET on February 26, 2026, either on the Teleflex website or by telephone.
The company has provided a detailed outline of its non-GAAP financial measures, describing metrics such as adjusted revenue, adjusted constant currency revenue growth, pro forma adjusted revenues, pro forma adjusted constant currency revenue growth, and adjusted diluted earnings per share, which are used by management to assess the company's financial performance and make operating decisions. As a result of these announcements, the company's shares have moved -1.54% on the market, and are now trading at a price of $103.00. For the full picture, make sure to review TELEFLEX INC's 8-K report.
